Skip to contentB
BioCardia, Inc.
B
BCDABioCardia, Inc. Q3 2021 · 10-Q
Revenue$821.00K$821.00K+2,314.7% vs Q3 2020 Net Income-$2.71M-$2.71MN/M vs Q3 2020 EPS Diluted-$0.16-$0.16N/M vs Q3 2020 Operating Income-$2,708,000N/M Operating Cash Flow
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
BioCardia, Inc. · CIK 925741 · Engraved from SEC EDGAR
derived
Free Cash Flowderived-$2,663,000N/M Margins · derivedOperating margin-329.8%+10987.8 pt vs Q3 2020
Net margin-329.6%+10988.0 pt vs Q3 2020
ended Sep 30, 2021 · filed Nov 10, 2021 · 41 d after period end